PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.05%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
3.38%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
8.35%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
8.35%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
11.66%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
10.00%
Positive EPS growth while TSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
12.82%
Positive diluted EPS growth while TSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.66%
Share reduction while TSM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.29%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.98%
Maintaining or increasing dividends while TSM cut them. John Neff might see a strong edge in shareholder returns.
105.33%
OCF growth above 1.5x TSM's 22.46%. David Dodd would confirm a clear edge in underlying cash generation.
134.07%
FCF growth above 1.5x TSM's 25.13%. David Dodd would verify if the firm’s strategic investments yield superior returns.
115.98%
10Y revenue/share CAGR at 50-75% of TSM's 155.69%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
30.54%
5Y revenue/share CAGR under 50% of TSM's 84.64%. Michael Burry would suspect a significant competitive gap or product weakness.
47.41%
3Y revenue/share CAGR at 75-90% of TSM's 54.99%. Bill Ackman would expect new product strategies to close the gap.
336.77%
10Y OCF/share CAGR above 1.5x TSM's 172.87%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
555.72%
5Y OCF/share CAGR above 1.5x TSM's 104.85%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
21.18%
3Y OCF/share CAGR under 50% of TSM's 69.33%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
293.57%
Net income/share CAGR above 1.5x TSM's 113.01% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
51.11%
5Y net income/share CAGR at 50-75% of TSM's 69.59%. Martin Whitman might see a shortfall in operational efficiency or brand power.
87.03%
3Y net income/share CAGR 1.25-1.5x TSM's 66.22%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
266.85%
10Y equity/share CAGR 1.25-1.5x TSM's 180.33%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
70.01%
5Y equity/share CAGR at 50-75% of TSM's 107.79%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
19.74%
Below 50% of TSM's 65.05%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.87%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
18.33%
Inventory growth well above TSM's 3.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.58%
Asset growth at 75-90% of TSM's 5.15%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
5.77%
BV/share growth above 1.5x TSM's 3.82%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.44%
Debt shrinking faster vs. TSM's 2.62%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
2.40%
We increase R&D while TSM cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.